Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Liquid Biopsies 2019

Filip Janku's Biography



Filip Janku, Associate Professor, Center Medical Director, Clinical and Translational Research Center, The University of Texas MD Anderson Cancer Center

Filip Janku, MD, PhD is Associate Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. Dr. Janku received his MD and PhD degrees from the Charles University, Prague, Czech Republic. Dr. Janku is principal investigator for numerous phase I trials, most of which involve novel, targeted agents, some of those being first-in-human studies. Dr. Janku received multiple awards for his research efforts, including four Merit Awards from ASCO as well as an American Association for Cancer Research Scholar-in-Training Award.

Filip Janku Image

Liquid Biopsies – A New Tool in the Personalized Cancer Therapy Toolbox

Thursday, 28 March 2019 at 09:00

Add to Calendar ▼2019-03-28 09:00:002019-03-28 10:00:00Europe/LondonLiquid Biopsies – A New Tool in the Personalized Cancer Therapy ToolboxLiquid Biopsies 2019 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

In the era of precision medicine, the optimal choice of cancer therapy depends upon analysis of the tumor genome. The spatial and temporal intratumor heterogeneity of cancers creates substantial challenges, as molecular profile depends on time and site of tumor tissue collection. Molecular analysis of liquid biopsies offers a novel, minimally invasive method that can be performed at multiple time-points and plausibly represents the prevailing molecular profile of the cancer. Molecular analysis of liquid biopsies offers multiple clinically useful applications, such as identification of molecular targets for cancer therapy, monitoring of tumor molecular profile in real time, detection of emerging molecular aberrations associated with resistance to particular therapy, determination of cancer prognosis and cancer recurrence or progression.


Add to Calendar ▼2019-03-27 00:00:002019-03-29 00:00:00Europe/LondonLiquid Biopsies 2019Liquid Biopsies 2019 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com